These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3897966)

  • 1. [Bronchial diffusion of piperacillin in 18 intensive care patients].
    Mouton Y; Caillaux M; Deboscker Y; Beuscart C; Beaucaire G; Fourrier A
    Pathol Biol (Paris); 1985 May; 33(5):359-62. PubMed ID: 3897966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diffusion of piperacillin into bronchial secretions].
    Bergogne-Bérézin E; Berthelot G; Kafe H
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):653-6. PubMed ID: 3534762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide, multicenter survey on the efficacy and safety of piperacillin for adult community-acquired pneumonia in Japan.
    Yamamoto Y; Watanabe A; Goto H; Matsushima T; Abe S; Aoki N; Shimokata K; Mikasa K; Niki Y; Kohno S
    J Infect Chemother; 2012 Aug; 18(4):544-51. PubMed ID: 22618270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and bacteriological evaluation of the efficacy of piperacillin in children with pneumonia.
    Aoki M; Fukao T; Kaneko H; Mizunaga S; Mitsuyama J; Sawamura H; Seishima M; Kondo N
    J Infect Chemother; 2007 Aug; 13(4):224-9. PubMed ID: 17721685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of piperacillin into bronchial mucosa and sputum.
    Marlin GE; Burgess KR; Burgoyne J; Funnell GR; Guinness MD
    Thorax; 1981 Oct; 36(10):774-80. PubMed ID: 6460337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of moxalactam in intensive care units: clinical and bacteriological results related to serum and bronchial concentrations ].
    Mouton Y; Beaucaire G; Caillaux M; Deboscker Y; Fourrier A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):495-500. PubMed ID: 6214758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Piperacillin in the newborn infant. A clinical and pharmacologic study].
    Kacet N; Zaoui C; Roussel-Delvallez M; Dubos JP; Martin GR; Lequien P
    Presse Med; 1986 Dec; 15(46):2339-41. PubMed ID: 2949281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose penicillin therapy and pneumococcal pneumonia.
    Brewin A; Arango L; Hadley WK; Murray JF
    JAMA; 1974 Oct; 230(3):409-13. PubMed ID: 4153372
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetics of mezlocillin in bronchial secretions (author's transl)].
    Bergogne-Berezin E; Pierre J; Even P; Reynaud P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):361-4. PubMed ID: 6460976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antagonist of the platelet-activating factor receptor inhibits adherence of both nontypeable Haemophilus influenzae and Streptococcus pneumoniae to cultured human bronchial epithelial cells exposed to cigarette smoke.
    Shukla SD; Fairbairn RL; Gell DA; Latham RD; Sohal SS; Walters EH; O'Toole RF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1647-55. PubMed ID: 27524890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal effect of ceftriaxone versus imipenem plus cilastatin in bronchial secretion.
    Fraschini F; Scaglione F; Cogo R; Casali W; Falchi M; Gattei G
    Chemotherapy; 1988; 34 Suppl 1():3-15. PubMed ID: 3073044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of piperacillin in bronchopulmonary infection.
    Marlin GE; Burgess KR; Thompson PJ
    J Int Med Res; 1981; 9(4):268-73. PubMed ID: 6455317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Penetration of mezlocillin into bronchial secretions (author's transl)].
    Morel C; Benard Y; Vergnaud M; Langeard M
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):365-7. PubMed ID: 6460977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of ceftriaxone.
    File TM; Tan JS; Salstrom SJ
    Clin Ther; 1984; 6(5):653-61. PubMed ID: 6090021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of thiamphenicol in the treatment of community-acquired lung infections].
    Raymond J; Boutros N; Bergeret M
    Med Trop (Mars); 2004; 64(1):33-8. PubMed ID: 15224555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections.
    Scaglione F; Scamazzo F; Arcidiacono MM; Cogo R; Monzani GP; Fraschini F
    J Chemother; 1995 Apr; 7(2):140-5. PubMed ID: 7666121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [penetration of fosfomycin into bronchial secretions].
    Berthelot G; Bergogne-Berezin E; Kafe H; Daumal M; Gillon JC
    Pathol Biol (Paris); 1983 Jun; 31(6):519-21. PubMed ID: 6348660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration of ofloxacin into bronchial secretions.
    Symonds J; Bone M; Turner A; Javaid A
    Drugs; 1987; 34 Suppl 1():33-6. PubMed ID: 3481325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various prospective approaches to the treatment of nonspecific lung diseases].
    Sil'vestrov VP; Vanina NF
    Ter Arkh; 1980; 52(3):3-12. PubMed ID: 6966837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.